Abvc Biopharma (ABVC) Change in Acquisitions & Divestments (2018)
Abvc Biopharma's (ABVC) quarterly Change in Acquisitions & Divestments came in at -$470666.0 in Q4 2018, down 329.06% on a QoQ basis from $205475.0 in Q3 2018.
Abvc Biopharma (ABVC) Change in Acquisitions & Divestments (2018) Analysis & Trends
Abvc Biopharma (ABVC) has 1 years of Change in Acquisitions & Divestments data on file, last reported at -$470666.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -470,666.00 |
| Dec 31, 2018 | -470,666.00 |
| Sep 30, 2018 | 205,475.00 |
| Sep 30, 2018 | 205,475.00 |